Cabaletta Bio Insider Trades
NASDAQ: CABAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 8 · $296.19K
- Sales
- 0 · $0
- Shares bought / sold
- 132.07K / 0
- Net activity
- Net buying $296,189
Cabaletta Bio insider activity
Over the last 12 months, Cabaletta Bio insiders reported 8 transactions on SEC Form 4: 8 open-market purchases and 0 sales. Insiders bought $296,189 and sold $0 worth of stock, for net insider buying of $296,189. The most recent filing shows Tomasello Shawn (Director) buying 22,725 shares at $2.21 on Jan 21, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CABA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CABA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jan 21, 2026 | Gerard MichaelGeneral Counsel | Buy | 6,600 | $14.98K | Form 4 |
| Jan 21, 2026 | Simon MarkDirector | Buy | 11,061 | $25.26K | Form 4 |
| Jan 21, 2026 | Binder GwendolynPresident, Science & Tech. | Buy | 11,312 | $24.76K | Form 4 |
| Jan 21, 2026 | Nichtberger StevenPresident & CEO | Buy | 45,000 | $100.78K | Form 4 |
| Jan 21, 2026 | Bollard CatherineDirector | Buy | 4,405 | $9.98K | Form 4 |
| Jan 21, 2026 | Chang David J.Chief Medical Officer | Buy | 8,800 | $19.89K | Form 4 |
| Jan 21, 2026 | Gavel SteveChief Commercial Officer | Buy | 22,170 | $50.22K | Form 4 |
| Jan 21, 2026 | Tomasello ShawnDirector | Buy | 22,725 | $50.32K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4